Performance evaluation of the Pima point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa

Journal of the International AIDS Society

Volumn 15, Issue 1, 2012, Pages

  Glencross, Deborah K ^a,b   Coetzee, Lindi M ^a,b   Faal, Mamsallah ^a   Masango, Martin ^c   Stevens, Wendy S ^a,b   Venter, W D Francois ^a   Osih, Regina ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b National Health Laboratory Service of South Africa   (South Africa)

^c Society for Family Health New Start HCT (HIV Counselling and Testing) Programme   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID;

ACCURACY; ARTICLE; BLOOD SAMPLING; CAPILLARY BLOOD; CD4+ T LYMPHOCYTE; HEALTH CARE FACILITY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SOUTH AFRICA; BLOOD; CD4 LYMPHOCYTE COUNT; EVALUATION; FEMALE; HOSPITAL INFORMATION SYSTEM; INSTRUMENTATION; MALE; METHODOLOGY;

BLOOD SPECIMEN COLLECTION; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; POINT-OF-CARE SYSTEMS; SOUTH AFRICA;

EID: 84856252817     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-15-3     Document Type: Article

References (49)

1. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phari JP, Rinaldo CR Jr, Ann Intern Med 1997 126 946 954 9182471 (Pubitemid 27255797)
2. Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Mocroft A, Youle M, Morcinek J, Sabin CA, Gazzard B, Johnson MA, Phillips AN, BMJ 1997 314 409 413 10.1136/bmj.314.7078.409 9040386 (Pubitemid 27067802)
3. Jourdain G, Ngo-Giang-Huong N, Le Coeur S, Traisaithit P, Barbier B, Techapornroong M, Banchongkit S, Buranabanjasatean S, Halue G, Lallemant M, PHPT-3 Study Group, PHPT-3: A Randomized Clinical Trial Comparing CD4 vs Viral Load ART Monitoring/Switching Strategies in Thailand Boston, USA 2011 18th Conference on Retrovirology and Opportunistic Infections. Paper # 44
4. The HIV & AIDS and STI Strategic Plan for South Africa (NSP 2007-2011) http://www.info.gov.za/otherdocs/2007/aidsplan2007/intro.pdf 22295152
5. National Health Laboratory Services. http://www.nhls.ac.za/
6. Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDS. Glencross DK, Janossy G, Coetzee LM, Lawrie D, Aggett HM, Scott LE, Sanne I, McIntyre JA, Stevens W, Cytometry B Clin Cytom 2008 74 Suppl 1 40 S51 18228554
7. Viewpoint: Why do we need a point-of-care CD4 test for low-income countries? Zachariah R, Reid SD, Chaillet P, Massaquoi M, Schouten EJ, Harries AD, Trop Med Int Health 2011 16 37 41 10.1111/j.1365-3156.2010.02669.x 21371207
8. Laboratory monitoring of HIV/AIDS in a resource-poor setting. Glencross DK, Mendelow BV, Stevens WS, S Afr Med J 2003 93 262 263 12806710 (Pubitemid 36603811)
9. Does POCT reduce the risk of error in laboratory testing? Plebani M, Clin Chim Acta 2009 404 59 64 10.1016/j.cca.2009.03.014 19298804
10. Point-of-care testing error: sources and amplifiers, taxonomy, prevention strategies, and detection monitors. Meier FA, Jones BA, Arch Pathol Lab Med 2005 129 1262 1267 16196514 (Pubitemid 41407431)
11. Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing. Jani IV, Sitoe NE, Chongo PL, Alfai ER, Quevedo JI, Tobaiwa O, Lehe JD, Peter TF, AIDS 2011 25 6 807 812 10.1097/QAD.0b013e328344f424 21378535
12. Earlier HIV diagnosis - are mobile services the answer? van Schaik N, Kranzer K, Wood R, Bekker LG, S Afr Med J 2010 100 671 674 21080998
13. Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness. Grabbe KL, Menzies N, Taegtmeyer M, Emukule G, Angala P, Mwega I, Musango G, Marum E, J Acquir Immune Defic Syndr 2010 54 317 323 10.1097/QAI.0b013e3181ced126 20453819
14. Active voluntary counseling and testing with integrated CD4 count service can enhance early HIV testing and early CD4 count measurement: experiences from the Thai Red Cross Anonymous Clinic in Bangkok, Thailand. Phanuphak N, Pattanachaiwit S, Pankam T, Pima W, Avihingsanon A, Teeratakulpisarn N, Phanuphak P, J Acquir Immune Defic Syndr 2011 56 244 252 10.1097/QAI. 0b013e318207597f 21157361
15. Providing Immediate CD4 Count Results at HIV Testing Improves ART Initiation. Faal M, Naidoo N, Glencross DK, Venter WD, Osih R, J Acquir Immune Defic Syndr 2011 58 54 e59 10.1097/QAI.0b013e3182303921 21857356
16. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. Mtapuri-Zinyowera S, Chideme M, Mangwanya D, Mugurungi O, Gudukeya S, Hatzold K, Mangwiro A, Bhattacharya G, Lehe J, Peter T, J Acquir Immune Defic Syndr 2010 55 1 7 10.1097/QAI.0b013e3181e93071 20622679
17. Comprehensive & cost effective laboratory monitoring of HIV/AIDS: an African role model. Lawrie D, Janossy G, Roos M, Glencross DK, J Vis Exp 2010
18. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC, BMJ 2003 326 41 44 10.1136/bmj.326.7379.41 12511463 (Pubitemid 36110721)
19. A model for continuous quality control incorporating sample-to-sample assessment of optical alignment, fluorescence sensitivity, and volumetric operation of flow cytometers. Lawrie D, Coetzee LM, Glencross DK, Cytometry B Clin Cytom 2010 78 201 210 20419764
20. The National Health Laboratory Service. http://www.nhls.ac.za
21. Monitoring reproducibility of single analysis, single platform CD4 cell counts in a high volume, low resource laboratory setting using sequential bead count rates. Scott LE, Glencross DK, Cytometry B Clin Cytom 2005 67 31 32 16100713 (Pubitemid 41291791)
22. African regional external quality assessment for CD4 T-cell enumeration: development, outcomes, and performance of laboratories. Glencross DK, Aggett HM, Stevens WS, Mandy F, Cytometry B Clin Cytom 2008 74 Suppl 1 69 79 18228560
23. UK NEQAS for leucocyte immunophenotyping: the first 10 years. Reilly JT, Barnett D, J Clin Pathol 2001 54 508 511 10.1136/jcp.54.7.508 11429420 (Pubitemid 32642937)
24. South African National Accreditation Scheme. http://www.sanas.co.za/
25. Coetzee LM, Aggett HM, Lawrie D, Glencross DK, Retrospective analysis of CD4 reporting error using a panel of stabilised blood AFREQAS samples with pre-established values 2009 49th Annual Congress of the Federation of the South African Societies of Pathology FSASP. South Africa.
26. Multiple method comparison: statistical model using percentage similarity. Scott LE, Galpin JS, Glencross DK, Cytometry B Clin Cytom 2003 54 46 53 12827667 (Pubitemid 38295418)
27. Statistical methods for assessing agreement between two methods of clinical measurement. Bland JM, Altman DG, Lancet 1986 1 307 310 2868172 (Pubitemid 16134762)
28. World Health Organization, Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach, Geneva. http://whqlibdoc.who.int/publications/2010/9789241599764-eng.pdf
29. Point-of-care method for total white cell count: an evaluation of the HemoCue WBC device. Osei-Bimpong A, Jury C, McLean R, Lewis SM, Int J Lab Hematol 2009 31 657 664 10.1111/j.1751-553X.2008.01093.x 18759736
30. Comparison of blood counts in venous, fingertip and arterial blood and their measurement variation. Yang ZW, Yang SH, Chen L, Qu J, Zhu J, Tang Z, Clin Lab Haematol 2001 23 155 159 10.1046/j.1365-2257.2001.00388.x 11553055 (Pubitemid 34204407)
31. th CROI-Conference Retrovirology and Opportunistic Infections. Abstract #947
32. Glencross DK, Coetzee L, Lawrie D, Stevens W, Osih R, Performance evaluation of PIMA CD4 Point-of-Care (POC) analyzer, Johannesburg, South Africa Vienna, Austria 2010 Poster presentation.XVIII International AIDS Conference 18-23 July
33. Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing. Jani IV, Sitoe NE, Chongo PL, Alfai ER, Quevedo JI, Tobaiwa O, Lehe JD, Peter TF, AIDS 2011 25 807 812 10.1097/QAD.0b013e328344f424 21378535
34. Laboratory medicine in Africa: a barrier to effective health care. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA, Clin Infect Dis 2006 42 377 382 10.1086/499363 16392084 (Pubitemid 43122314)
35. Multi-site evaluation of a point-of-care CD4 instrument for CD4+ T-cell enumeration using venous and finger prock blod: the PIMA CD4. Diaw PA, Daneau G, Coly AZ, Ndiaye BP, Wade D, Camra M, Mboup S, Kestens L, Dieye TN, J AIDS 2011
36. Quality assurance, practical management, and outcomes of point-of-care testing: laboratory perspectives, Part I. Nichols JH, Poe SS, Clin Lab Manage Rev 1999 13 341 350 10747660
37. Errors in laboratory medicine. Bonini P, Plebani M, Ceriotti F, Rubboli F, Clin Chem 2002 48 691 698 11978595 (Pubitemid 34439100)
38. Absolute and percent CD4+ T-cell enumeration by flow cytometry using capillary blood. Sitoe N, Luecke E, Tembe N, Matavele R, Cumbane V, Macassa E, Vaz P, Sheppard H, Jani IV, J Immunol Methods 2011
39. Analysis of POCT/VCT performed at South African primary health care clinics. http://www.sead.co.za/downloads/POCT-clinics-2011.pdf
40. Performance Evaluation of the Alere PIMA CD4 Test for Monitoring HIV-Infected Individuals in Resource-Constrained Settings. Sukapirom K, Onlamoon N, Thepthai C, Polsrila K, Tassaneetrithep B, Pattanapanyasat K, J Acquir Immune Defic Syndr 2011 58 141 147 10.1097/QAI.0b013e31822866a2 21709568
41. Knowledge Of A CD4 Count Result At The Time Of HIV Diagnosis Improves Pre-ART Patient Retention, But Loss To Follow-Up Remains High. Faal M, Naidoo N, Glencross DK, WDF V, Osih R, J AIDS 2011
42. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort. Glencross DK, Janossy G, Coetzee LM, Lawrie D, Scott LE, Sanne I, McIntyre JA, Stevens W, Cytometry B Clin Cytom 2008 74 Suppl 1 131 140 18228566
43. th Conference on Retrovirology and Opportunistic Infections. Abstract 45LB
44. Good clinical laboratory practice (GCLP): the need for a hybrid of good laboratory practice and good clinical practice guidelines/standards for medical testing laboratories conducting clinical trials in developing countries. Stevens WS, Quality Assurance 2003 10 82 89
45. Osih R, POC and FACSCount Vienna, Austria 2010 XVIII IAS: International AIDS Conference
46. Scott LE, Gous N, Cunningham B, Nduna M, Stevens WS, Anticipating hurdles for implementing HIV/TB diagnosis and monitoring using multiple Point of Care platforms 2011 South African AIDS meeting. South Africa
47. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health care clinics: an observational cohort study. Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, Lehe JD, Peter TF, The Lancet 2011 378 9802 1572 1579 10.1016/S0140-6736(11)61052-0
48. Imperial College CD4 Initiative. http://www3.imperial.ac.uk/cd4
49. UNITAID 2011: HIV/AIDS Diagnostic Landscape. http://unitaid.eu/images/ marketdynamics/publications/unitaid-md-technical-report-diagnostics-landscape- web.pdf